title: Raising the bar of efficacy for drug approval requires an understanding of patient diversity.
authors.forename: Marc L
authors.initials: ML
authors.lastname: Berger
authors.forename: Stephen
authors.initials: S
authors.lastname: Eck
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Ruberg
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D007206:Individuality; D009369:Neoplasms / Q000188:drug therapy; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents